RE:RE:RE:Be careful, 7012700 more shares are floatingTweedlede wrote: PotStocker wrote: PotStocker wrote:
Last time, the 7012700 shares were designed to be accessed by two steps. And now, they were accessed in full. This can be interpreted as 1, Dundee sees a bright future for cgc so they buy them all and will hold them. 2, Dundee sees the chance to profit so they buy them all and sell(or sold already, this is to cover its short positions). Not sure which way it is. SMITHS FALLS, ON, Nov. 18, 2015 /CNW/ - Canopy Growth Corporation ("Canopy" or the "Company") (TSXV: CGC), is pleased to announce that it has closed its previously announced short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters' over-allotment option. A total of 7,012,700 common shares in the capital of the Company (the "Shares") were sold at a price of $2.05 per Share, for aggregate gross proceeds of $14,376,035.00 (the "Offering").
This means the total share as of today is 98.5M shares. cgc has almost doubled its shares since IPO -- in 19 months
I would not be surprised to see it double in another 2 years again. This is not a bad thing for a small cap growth company. I don't need to see dividends. I need to see aggressive market share acquisition.
I would agree with you on one condition. cgc is able to grow per share value -- this means the market share need to be doubled alone with its number of shares floating. Right now, the media said cgc is to control half of the market, some said it is to control 40%, then now, they said it has control 20%. Before the merge, cgc had 3000 patients and now, 6000 patients does not mean it is making progress. Because without mergers, MT has controlled 19.375% of market shares(4650 patients) and APH has controlled 11.875%(2850 patients). So, where should be put cgc at? In short, growing fast is good only when cgc grows efficiently at the same time. Otherwise, it is wasting share holders money!